Pitcairn Co. Buys 649 Shares of Integer Holdings Co. (NYSE:ITGR)

Pitcairn Co. boosted its stake in Integer Holdings Co. (NYSE:ITGR) by 11.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,427 shares of the medical equipment provider’s stock after acquiring an additional 649 shares during the period. Pitcairn Co.’s holdings in Integer were worth $750,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. boosted its holdings in shares of Integer by 483.3% during the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock worth $45,000 after buying an additional 377 shares in the last quarter. Principal Securities Inc. bought a new position in shares of Integer during the 4th quarter worth approximately $67,000. Headlands Technologies LLC bought a new position in shares of Integer during the 1st quarter worth approximately $106,000. Quadrant Capital Group LLC boosted its holdings in shares of Integer by 10.2% during the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock worth $141,000 after buying an additional 132 shares in the last quarter. Finally, Strs Ohio boosted its holdings in shares of Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock worth $168,000 after buying an additional 600 shares in the last quarter. 99.29% of the stock is currently owned by institutional investors.

Integer Price Performance

Shares of ITGR traded down $8.87 during trading hours on Thursday, reaching $115.68. 1,090,660 shares of the company’s stock traded hands, compared to its average volume of 329,731. The stock has a market cap of $3.88 billion, a PE ratio of 40.13, a price-to-earnings-growth ratio of 1.86 and a beta of 1.11. The company has a current ratio of 3.32, a quick ratio of 2.01 and a debt-to-equity ratio of 0.76. The firm’s 50 day simple moving average is $119.17 and its 200-day simple moving average is $113.03. Integer Holdings Co. has a 12 month low of $69.40 and a 12 month high of $130.15.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. The firm had revenue of $414.80 million during the quarter, compared to the consensus estimate of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the company posted $0.87 EPS. Equities analysts expect that Integer Holdings Co. will post 5.27 EPS for the current year.

Insider Activity

In related news, SVP Andrew Senn sold 5,000 shares of Integer stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total transaction of $565,700.00. Following the sale, the senior vice president now directly owns 4,658 shares in the company, valued at $527,006.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the sale, the vice president now directly owns 2,813 shares in the company, valued at $320,682. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Andrew Senn sold 5,000 shares of Integer stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total value of $565,700.00. Following the sale, the senior vice president now owns 4,658 shares in the company, valued at $527,006.12. The disclosure for this sale can be found here. In the last 90 days, insiders sold 17,936 shares of company stock worth $2,130,937. 2.00% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ITGR. KeyCorp upped their target price on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 9th. Benchmark reaffirmed a “buy” rating and set a $130.00 target price on shares of Integer in a research report on Friday, May 10th. Truist Financial assumed coverage on Integer in a research note on Wednesday, May 15th. They set a “buy” rating and a $137.00 price target for the company. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and raised their target price for the stock from $105.00 to $135.00 in a research note on Monday, April 15th. Finally, Citigroup raised their target price on Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 22nd. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Integer has a consensus rating of “Moderate Buy” and an average price target of $128.88.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.